Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.79
+0.08 (1.40%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Aura Biosciences Employees
As of December 31, 2024, Aura Biosciences had 109 total employees, including 106 full-time and 3 part-time employees. The number of employees increased by 20 or 22.47% compared to the previous year.
Employees
109
Change (1Y)
20
Growth (1Y)
22.47%
Revenue / Employee
n/a
Profits / Employee
-$797,422
Market Cap
289.30M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 109 | 20 | 22.47% |
Dec 31, 2023 | 89 | 17 | 23.61% |
Dec 31, 2022 | 72 | 20 | 38.46% |
Dec 31, 2021 | 52 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AURA News
- 22 days ago - Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - GlobeNewsWire
- 4 weeks ago - Aura Biosciences, Inc (AURA) Virtual Urologic Oncology Investor Event Call (Transcript) - Seeking Alpha
- 4 weeks ago - Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 4 weeks ago - Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress - GlobeNewsWire
- 7 weeks ago - Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress - GlobeNewsWire
- 2 months ago - Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Muscle Invasive Bladder Cancer Drug Pipeline Market Research 2024 Featuring Aura Biosciences, Janssen Research & Development, Asieris Pharmaceuticals, and RemeGen - GlobeNewsWire
- 6 months ago - Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha